The Clinical Efficacy of Next Science Wound Gel (NXTSC) in the Healing of Chronic Wounds

Completed · Not applicable

Conditions studied: Wound Infection

In brief

Determine the effect on wound treatment outcomes using a novel antimicrobial wound gel (NXTSC) for the treatment of infected wounds as the sole topical treatment of microbial infection at the wound site.

Key facts

Study ID

NCT02465073

Run by

Southwest Regional Wound Care Center

People needed

49

Starts

2013-07-01

Expected to finish

2015-03-01

Last updated by the study team

2019-11-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The subject must have a full-thickness chronic wound for greater than one month.
• The subject must be at least 18 years of age.
• The ulcer to be biopsied must be greater than 1 centimeter in area.
• The subject must be able to give informed consent.

You may not qualify if…

• Medical or emotional risk associated with the potential biopsy that outweighs the risk of not taking a biopsy as determined by the investigator.
• Those patients that have significant contributions from other disease processes such as arterial disease (Ankle Brachial Index [ABI] less than .7, OR Transcutaneous Partial Oxygen Pressure [TCpO2 ] less than 20) will be considered to have mixed vascular disease producing their wound and will be excluded from the study.

Where it is running

• Southwest Regional Wound Care Center — Lubbock, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.